WHO Releases First Global Tobacco Cessation Guidelines
The new guidelines recommend a combination of behavioral support, digital cessation tools, and pharmacological treatments to aid tobacco cessation in adults.
The new guidelines recommend a combination of behavioral support, digital cessation tools, and pharmacological treatments to aid tobacco cessation in adults.
The new guidelines recommend a combination of behavioral support, digital cessation tools, and pharmacological treatments to aid tobacco cessation in adults.
Read MoreSmokers were more likely to quit on their second attempt if doses of the smoking cessation drug varenicline (Chantix) were increased, a JAMA study revealed.
Read MorePfizer has expanded its voluntary recall of smoking cessation drug Chantix, according to an update posted on the US FDA website.
Read MoreA new ATS clinical practice guideline on treatment for tobacco dependence in adults recommends the use of varenicline (aka Chantix, Champix) over nicotine patch or buproprion.
Read MoreThe FDA will no longer require smoking cessation pharmaceuticals like Chantix and Zyban to carry special warnings about possible psychiatric side effects, the agency announced on Friday.
Read MoreFederal regulators say Pfizer has provided low-quality evidence to support its request to remove a bold-letter warning from its anti-smoking drug Chantix about suicidal behavior.
Read MorePatients prescribed either bupropion (Zyban) or varenicline (Chantix), are no more likely to get depressed, commit suicide or harm themselves than those prescribed nicotine replacement therapy (NRT), according research published in BMJ.
Read MoreResearchers from Pfizer report on the first clinical trial studying the safety, tolerability, and pharmacokinetics of the drug varenicline on 65 to 75 year-old smokers.
Read MoreChantix is designed to partially activate the nicotinic receptor and reduce the severity of the smoker’s craving and the withdrawal symptoms from nicotine.
Read More